238.4K
Downloads
230
Episodes
Allen & Overy is an international legal practice and trusted counsel to the world’s leading companies, financial institutions and public sector organisations. In this series of podcasts, our lawyers share their perspectives on today’s most significant global legal, regulatory and commercial issues. Disclaimer: Podcasts are not legal advice. Laws may have changed since a podcast was recorded.
Episodes
Monday Sep 25, 2023
Monday Sep 25, 2023
A new video podcast series by Allen & Overy called Voices for Change, for inclusive thinkers and doers. Join Justin Farrance, A&O’s DE&I Ambassador, as he interviews colleagues from across A&O, as well as clients and alumni about their personal stories, commitment on DE&I and advice for others to learn from. Stay up to date with new episodes announced each month.
First up, Senior Partner Wim Dejonghe talks to Justin about his early years in law, as well as why “the biggest risk for any successful organisation is to become complacent with DE&I, because the world will catch up with you.”
Monday Sep 25, 2023
Monday Sep 25, 2023
A new video podcast series by Allen & Overy called Voices for Change, for inclusive thinkers and doers. Join Justin Farrance, A&O’s DE&I Ambassador, as he interviews colleagues from across A&O, as well as clients and alumni about their personal stories, commitment on DE&I and advice for others to learn from. Stay up to date with new episodes announced each month.
First up, Senior Partner Wim Dejonghe talks to Justin about his early years in law, as well as why “the biggest risk for any successful organisation is to become complacent with DE&I, because the world will catch up with you.”
Friday Sep 22, 2023
Friday Sep 22, 2023
The regulatory frameworks for medicines and medical devices have historically grown up on separate tracks, but increasingly, medicines and medical devices are being used together in patients as drug device combinations, companion diagnostics and medical devices used in clinical trials.
Join Sapna Palla, Eda Zhuleku and Rafi Allos in part one of this podcast series to discuss the use of medical devices in clinical trials and the different perspectives between the EU and U.S., as well as the regulatory requirements that may apply.
Monday Sep 11, 2023
Monday Sep 11, 2023
Net Asset Value or NAV financing is gaining popularity among private equity and other alternative asset managers seeking liquidity in a challenging market.
In the first episode of Private Capital Perspectives, Hong Kong banking and finance partner Patrick Wong and structured finance lawyer Jamie Taylor discuss how NAV financing works, why it is increasingly in vogue among APAC investors, and the issues to consider when structuring and executing NAV deals.
Wednesday Sep 06, 2023
Wednesday Sep 06, 2023
The European Commission have published the long awaited proposals for major revision of pharmaceutical law in the European Union.
In our latest life sciences podcast, Rafi Allos and Tine Carmeliet discuss the new directive and new regulation under the legislation with much anticipated change to happen.
Tuesday Sep 05, 2023
Episode 7: Deconstructing Crypto – What next after Ripple?
Tuesday Sep 05, 2023
Tuesday Sep 05, 2023
In the latest podcast, Todd Fishman and Gene Ingoglia discuss the impact of the long-awaited decision on the Ripple Labs case. Read here for our client alert on this decision.
In SEC v. Ripple Labs, the U.S. Securities and Exchange Commission (“SEC”) alleges that Ripple Labs, Inc. and two of its executives raised over $1.3 billion through an unregistered and ongoing digital asset securities offering (XRP). Almost immediately, this decision created a number of waves and cross-currents across the crypto ecosystem.
Soon after, in SEC v. Terraform Labs, District Judge Jed Rakoff issued a decision that alleged the Terraform (UST) stablecoin and the related Luna token are investment contracts for all purposes within the meaning of the US securities laws.
So where does this leave us and what do businesses need to pay attention to?
Tune in to the podcast, where Todd and Gene shares their views on what next after Ripple.
Wednesday Aug 23, 2023
Women in Funds: Conversation with Anna Budd and Ruth Jackson at Hines
Wednesday Aug 23, 2023
Wednesday Aug 23, 2023
In this episode of Women in Funds, Funds & Asset Management partner Emma Danforth (London) and associate William Michell (London) have an insightful discussion with Anna Budd, Senior Managing Director and Co-Head of Legal at Hines, and Ruth Jackson, Managing Director and Deputy Fund Manager at Hines. The conversation revolves around a range of diversity, equity & inclusion and career development topics, including the value of mentorship, how to thrive in a male-dominated industry, career advice to junior female professionals, and generational diversity in the workplace.
About speakers
Anna Budd is a Senior Managing Director and Co-Head of Legal at Hines overseeing a global team of over 40 people. Since joining the firm in 2017, she now has prime responsibility for all legal operations outside the US spanning Europe and APAC, as well as overseeing legal support for Hines’ global investment management business. Anna has significant experience in real estate investments, developments, financing, corporate transactions, as well as real estate funds and joint ventures. Anna plays a key role in Hines’ D&I efforts, most notably through her role as Co-Chair of the One Hines Women’s Network. Anna is also part of Hines’ mentoring programme, mentoring several women both inside and outside Hines.
Ruth Jackson is a Managing Director and Deputy Fund Manager at Hines. She joined Hines in July 2018 and is the Deputy Fund Manager for the flagship Hines European Value Fund Series which manages c.€1.8bn of equity across the first two funds and is fundraising now for HEVF 3, raising over €1.45bn to date with final closing in November. Prior to Hines, she was the Portfolio Manager on a +€3.0 billion pan-European open-ended Fund at Invesco Real Estate for approximately 5 years. Ruth started her career, after graduating from Cambridge University, at JLL advising clients on investments and developments in central London.
Friday Aug 11, 2023
Friday Aug 11, 2023
Join Allen & Overy partners Gene Ingoglia and Claire Rajan as they analyze the regulatory enforcement developments in the world of AI. In this podcast, Gene and Claire dive into SEC Chair Gary Gensler’s speech to the National Press Club on July 17, and provide their insight on the four key areas discussed by Mr Gensler; (i) The potential for conflicts of interest; (ii) The potential for fraud and deception; (iii) The impact on privacy and intellectual property issues - so, whose data is it?; (iv) The impact on financial stability. This speech was soon followed by the SEC’s new proposed rulemaking, which Gene and Claire give their view on and how this will affect the regulation of the AI space moving forward.
Gene and Claire also discuss the Fed weighing in on AI’s impact on the financial sector and the probe launched into the use of AI in the securities industry by Massachusetts Secretary of State William Galvin, by seeking information from firms using or developing AI on what supervisory procedures are in place and how they plan to use AI.
Wednesday Aug 09, 2023
Regulatory developments in carbon leakage and carbon border adjustment mechanisms
Wednesday Aug 09, 2023
Wednesday Aug 09, 2023
In this episode of A&O’s sustainability podcast series, Matthew Townsend, Arthur Sauzay and Ying-Peng Chin from A&O’s International Environmental, Climate and Regulatory Law Group discuss recent regulatory developments in carbon leakage and carbon border adjustment mechanisms, in particular the EU CBAM and key global trends in this space.
Monday Aug 07, 2023
Monday Aug 07, 2023
In this second episode of Allen & Overy’s Market Horizons podcast series on the political agreement of the draft EU Green Bond Regulation, Maria Green, a Counsel PSL who supports A&O global securitisation practice, and Axel de Backer, a Senior Associate in A&O’s Banking & International Capital Markets practice in Brussels, look at this new Regulation from the securitisation perspective.
Together, they analyse why the new European Green Bond label could present challenges for securitisation transactions and give rise to new complex disclosure considerations.
In addition to this podcast, please also refer to the discussion of the draft Regulation from the mainstream debt perspective, which was covered in the podcast of 29 June 2023 “The EU Goes for gold with its Green Bond Regulation” and a related article.